Arcutis Biotherapeutics, Inc. financial data

Symbol
ARQT on Nasdaq
Location
Westlake Village, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 334% % -29%
Quick Ratio 18% % 16%
Debt-to-equity 138% % 2.1%
Return On Equity -10% % 87%
Return On Assets -4.3% % 87%
Operating Margin -3.2% % 95%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124,033,382 shares 4.1%
Common Stock, Shares, Outstanding 123,332,672 shares 4.7%
Entity Public Float $1,527,940,146 USD 55%
Common Stock, Value, Issued $12,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 127,234,000 shares 5.2%
Weighted Average Number of Shares Outstanding, Diluted 127,234,000 shares 5.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $376,072,000 USD 91%
Research and Development Expense $77,051,000 USD 0.83%
Costs and Expenses $388,299,000 USD 19%
Operating Income (Loss) $12,227,000 USD 90%
Income Tax Expense (Benefit) $1,171,000 USD 81%
Net Income (Loss) Attributable to Parent $16,141,000 USD 88%
Earnings Per Share, Basic -0.13 USD/shares 89%
Earnings Per Share, Diluted -0.13 USD/shares 89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $42,907,000 USD -40%
Accounts Receivable, after Allowance for Credit Loss, Current $146,229,000 USD 100%
Inventory, Net $22,634,000 USD 56%
Assets, Current $411,232,000 USD 22%
Property, Plant and Equipment, Net $1,043,000 USD 0.19%
Operating Lease, Right-of-Use Asset $4,467,000 USD 129%
Intangible Assets, Net (Excluding Goodwill) $14,812,000 USD 56%
Other Assets, Noncurrent $1,419,000 USD 138%
Assets $432,973,000 USD 24%
Accounts Payable, Current $12,528,000 USD -12%
Employee-related Liabilities, Current $20,533,000 USD -1%
Accrued Liabilities, Current $116,310,000 USD 74%
Liabilities, Current $129,838,000 USD 60%
Operating Lease, Liability, Noncurrent $5,266,000 USD 106%
Other Liabilities, Noncurrent $431,000 USD -24%
Liabilities $243,494,000 USD 27%
Accumulated Other Comprehensive Income (Loss), Net of Tax $44,000 USD -529%
Retained Earnings (Accumulated Deficit) $1,138,084,000 USD -1.4%
Stockholders' Equity Attributable to Parent $189,479,000 USD 20%
Liabilities and Equity $432,973,000 USD 24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $30,380,000 USD 3.9%
Net Cash Provided by (Used in) Financing Activities $395,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $11,750,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 123,332,672 shares 4.7%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $18,231,000 USD -118%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $43,215,000 USD -40%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,568,000 USD -61%
Deferred Tax Assets, Valuation Allowance $255,482,000 USD -0.31%
Deferred Tax Assets, Gross $256,696,000 USD -0.1%
Operating Lease, Liability $5,560,000 USD 64%
Depreciation $153,000 USD -10%
Payments to Acquire Property, Plant, and Equipment $608,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $16,178,000 USD 88%
Lessee, Operating Lease, Liability, to be Paid $8,144,000 USD 113%
Property, Plant and Equipment, Gross $4,291,000 USD 19%
Operating Lease, Liability, Current $294,000 USD -64%
Lessee, Operating Lease, Liability, to be Paid, Year Two $545,000 USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year One $792,000 USD -23%
Operating Lease, Weighted Average Discount Rate, Percent 0.093 pure 33%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,584,000 USD 493%
Lessee, Operating Lease, Liability, to be Paid, Year Three $862,000 USD -21%
Deferred Tax Assets, Operating Loss Carryforwards $180,809,000 USD 5.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $43,382,000 USD 2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,255,000 USD 92%
Additional Paid in Capital $1,327,595,000 USD 3.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,979,000 USD 1485%
Deferred Tax Assets, Net of Valuation Allowance $1,214,000 USD 75%
Share-based Payment Arrangement, Expense $40,364,000 USD -3.3%
Interest Expense $30,150,000 USD 45%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%